Familial Chylomicronemia Syndrome
📧 Sign up to get email alerts when something new happens for Familial Chylomicronemia Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2024-12-27Clinical Trial Update: Olezarsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)
This update notes that Olezarsen has been approved for marketing under an Early Access Program for patients with Familial Chylomicronemia Sy…
-
FDA approval · 2024-12-19FDA Approved: TRYNGOLZA — Original Application (Ionis Pharmaceuticals, Inc.)
FDA approves TRYNGOLZA (olesarsen sodium) from Ionis Pharmaceuticals as a new molecular entity for the treatment of severe hypertriglyceride…